Status:
COMPLETED
Astaxanthin Reduces Exercising Heart Rate.
Lead Sponsor:
University of North Alabama
Conditions:
Metabolic Flexibility
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Briefly, this study involved 2 trials: baseline (Trial 1) and post-astaxanthin intervention (Trial 2). Both trials included participants completing a graded exercise test while connected to a metaboli...
Detailed Description
METHODS Experimental Design The current study implemented a double-blind, between-subject study design with dependent variables examined at multiple timepoints across each trial. To best observe cha...
Eligibility Criteria
Inclusion
- Free of any cardiometabolic disease medication
- Classified as overweight - body fat % ≥ 20% (M) and ≥ 25% (F)
- Exclude dietary supplements for 2 weeks prior to start of study
Exclusion
- If there is a chance of pregnancy
- body fat % \< 20% (M) and \< 25% (F)
Key Trial Info
Start Date :
May 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2021
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT05282355
Start Date
May 12 2021
End Date
July 2 2021
Last Update
March 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Alabama, Department of Kinesiology
Florence, Alabama, United States, 35630